Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study-Reference-Cited by-同舟云学术

Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study

Published:2024-08 Issue: Volume:596 Page:217001
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Fletcher Kylie^ORCID,Cortellini Alessio^ORCID,Ganta Teja^ORCID,Kankaria Roma^ORCID,Song Haocan,Ye Fei^ORCID,Irlmeier Rebecca,Debnath Neha,Saeed Anwaar,Radford Maluki,Alahmadi Asrar^ORCID,Diamond Akiva^ORCID,Hoimes Christopher^ORCID,Presley Carolyn J.,Owen Dwight H.^ORCID,Abou Alaiwi Sarah,Nassar Amin H.^ORCID,Lamberti Giuseppe^ORCID,Perrone Fabiana^ORCID,Buti Sebastiano^ORCID,Giusti Raffaele^ORCID,Filetti Marco^ORCID,Vanella Vito,Mallardo Domenico,Sussman Tamara A.^ORCID,Galetta Domenico^ORCID,Kalofonou Foteini,Daniels Ella,Ascierto Paolo A.^ORCID,Pinato David J.,Nebhan Caroline,Berg Stephanie^ORCID,Choueiri Toni K.,Marron Thomas U.^ORCID,Wang Yinghong,Naqash Abdul Rafeh,Johnson Douglas B.^ORCID

Funder

National Cancer Institute

Associazione Italiana per la Ricerca sul Cancro

LUNGevity Foundation

VANDERBILT UNIVERSITY

Publisher

Elsevier BV

Reference10 articles.

1. Efficacy and adverse events of immunotherapy with checkpoint inhibitors in older patients with cancer;van Holstein;Drugs Aging,2019

2. Demographic factors associated with toxicity in patients treated with anti-programmed cell death-1 therapy;Shah;Cancer Immunol. Res.,2020

3. Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations;Kugel;Clin. Cancer Res.,2018

4. Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer;Johns;Journal of Geriatric Oncology,2021

5. Frailty in older people;Lancet,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short- and Long-Term Outcomes in Elderly Patients with Resectable Esophageal Cancer: Upfront Esophagectomy Compared to Surgery after Neoadjuvant Treatments;Journal of Clinical Medicine;2024-07-22